title: S(+)-ibuprofen (dexibuprofen)--Excellent tolerance has not to be combined with poor clinical efficacy.
abstract: S(+)-ibuprofen (dexibuprofen) is an NSAID offering a lot of advantages in the treatment of rheumatism and pain. A randomized double-blind, parallel group study in 110 patients showed equivalence in efficacy of 900 mg dexibuprofen (Seractil 300 mg, Gebro Fieberbrunn, Austria) vs. 150 mg diclofenac sodium. Regarding tolerance there was a trend to superiority of dexibuprofen. Therefore dexibuprofen can be characterized as an effective and very tolerable drug against inflammation and pain.
authors.affiliation: Gebro Broschek GmbH, A-6391, Fieberbrunn.
authors.forename: A
authors.initials: A
authors.lastname: Zohmann
authors.forename: R
authors.initials: R
authors.lastname: Hawel
authors.forename: G
authors.initials: G
authors.lastname: Klein
authors.forename: W
authors.initials: W
authors.lastname: Kullich
authors.forename: G
authors.initials: G
authors.lastname: Lötsch